Logo image of BTMD

BIOTE CORP -A (BTMD) Stock Price, Quote, News and Overview

NASDAQ:BTMD - Nasdaq - US0906831039 - Common Stock - Currency: USD

3.595  +0.07 (+1.84%)

After market: 3.74 +0.15 (+4.03%)

BTMD Quote, Performance and Key Statistics

BIOTE CORP -A

NASDAQ:BTMD (5/29/2025, 8:00:01 PM)

After market: 3.74 +0.15 (+4.03%)

3.595

+0.07 (+1.84%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High8.44
52 Week Low3.04
Market Cap181.94M
Shares50.61M
Float28.77M
Yearly DividendN/A
Dividend YieldN/A
PE5.53
Fwd PE7.29
Earnings (Next)08-06 2025-08-06/amc
IPO03-02 2021-03-02


BTMD short term performance overview.The bars show the price performance of BTMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

BTMD long term performance overview.The bars show the price performance of BTMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of BTMD is 3.595 USD. In the past month the price increased by 7.96%. In the past year, price decreased by -46.02%.

BIOTE CORP -A / BTMD Daily stock chart

BTMD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 52.51 684.81B
JNJ JOHNSON & JOHNSON 15.28 369.52B
NVO NOVO-NORDISK A/S-SPONS ADR 19.51 308.64B
NVS NOVARTIS AG-SPONSORED ADR 13.55 222.36B
AZN ASTRAZENECA PLC-SPONS ADR 16.11 219.72B
MRK MERCK & CO. INC. 9.81 191.84B
PFE PFIZER INC 7.31 133.32B
SNY SANOFI-ADR 11.9 127.40B
BMY BRISTOL-MYERS SQUIBB CO 6.52 97.38B
GSK GSK PLC-SPON ADR 9.03 81.17B
ZTS ZOETIS INC 27.76 74.41B
HLN HALEON PLC-ADR 23.12 51.02B

About BTMD

Company Profile

BTMD logo image biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

Company Info

BIOTE CORP -A

1875 W. Walnut Hill Ln #100, Floor 5

Irving TEXAS US

Employees: 194

BTMD Company Website

BTMD Investor Relations

Phone: 19724869346

BIOTE CORP -A / BTMD FAQ

What is the stock price of BIOTE CORP -A today?

The current stock price of BTMD is 3.595 USD. The price increased by 1.84% in the last trading session.


What is the ticker symbol for BIOTE CORP -A stock?

The exchange symbol of BIOTE CORP -A is BTMD and it is listed on the Nasdaq exchange.


On which exchange is BTMD stock listed?

BTMD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BIOTE CORP -A stock?

12 analysts have analysed BTMD and the average price target is 7.62 USD. This implies a price increase of 111.85% is expected in the next year compared to the current price of 3.595. Check the BIOTE CORP -A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOTE CORP -A worth?

BIOTE CORP -A (BTMD) has a market capitalization of 181.94M USD. This makes BTMD a Micro Cap stock.


How many employees does BIOTE CORP -A have?

BIOTE CORP -A (BTMD) currently has 194 employees.


What are the support and resistance levels for BIOTE CORP -A (BTMD) stock?

BIOTE CORP -A (BTMD) has a support level at 3.33 and a resistance level at 4.11. Check the full technical report for a detailed analysis of BTMD support and resistance levels.


Is BIOTE CORP -A (BTMD) expected to grow?

The Revenue of BIOTE CORP -A (BTMD) is expected to grow by 3.12% in the next year. Check the estimates tab for more information on the BTMD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOTE CORP -A (BTMD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOTE CORP -A (BTMD) stock pay dividends?

BTMD does not pay a dividend.


When does BIOTE CORP -A (BTMD) report earnings?

BIOTE CORP -A (BTMD) will report earnings on 2025-08-06, after the market close.


What is the Price/Earnings (PE) ratio of BIOTE CORP -A (BTMD)?

The PE ratio for BIOTE CORP -A (BTMD) is 5.53. This is based on the reported non-GAAP earnings per share of 0.65 and the current share price of 3.595 USD. Check the full fundamental report for a full analysis of the valuation metrics for BTMD.


What is the Short Interest ratio of BIOTE CORP -A (BTMD) stock?

The outstanding short interest for BIOTE CORP -A (BTMD) is 3.1% of its float. Check the ownership tab for more information on the BTMD short interest.


BTMD Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to BTMD. When comparing the yearly performance of all stocks, BTMD is a bad performer in the overall market: 89.04% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BTMD Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BTMD. BTMD has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BTMD Financial Highlights

Over the last trailing twelve months BTMD reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 490.91% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.85%
ROA 13.68%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%716.67%
Sales Q2Q%4.67%
EPS 1Y (TTM)490.91%
Revenue 1Y (TTM)31.42%

BTMD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to BTMD. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 170.45% and a revenue growth 3.12% for BTMD


Ownership
Inst Owners67.42%
Ins Owners27.6%
Short Float %3.1%
Short Ratio3.76
Analysts
Analysts83.33
Price Target7.62 (111.96%)
EPS Next Y170.45%
Revenue Next Year3.12%